欧美日韩一本二本|国产自产视频|日本1区2区3区不卡|国产精品无码午夜在线免费看

浙江健新原力制藥有限公司
屏蔽該公司
取消屏蔽

制藥· 100-499人· A輪

浙江健新原力制藥有限公司落戶于杭州臨空經(jīng)濟示范區(qū),是杭州灣生物科技谷核心企業(yè),總投資20億元,創(chuàng)始人余國良博士和李玉玲博士均為CBA前任會長。公司一期占地面積約125畝,總建筑面積約18萬平方米,建設包括生物醫(yī)藥工藝開發(fā)實驗室,小試和中試基地,若干條商業(yè)化單克隆抗體生產(chǎn)線,細胞治療和基因治療的開發(fā)產(chǎn)能。健新原力的目標是建立符合全球標準的生物藥制造能力,帶動中國和全球主要市場間生物創(chuàng)新藥物的研發(fā)和商業(yè)轉(zhuǎn)化趨勢。 2018年度蕭山“5213”項目重點企業(yè) 2018年度蕭山金鳳凰企業(yè)2018年度空港經(jīng)濟區(qū)重點企業(yè) 2018年度全省僑界“十佳”回國投資創(chuàng)業(yè)企業(yè) 2019年度蕭山金鳳凰企業(yè) 2019年杭州市“大好高”項目 2019年新原力生物技術全球高峰論壇成功舉辦 2019年余國良董事長榮獲全球浙商金獎 Why Join Innoforce: We not only offer a dream location and competitive compensation package, but more importantly also provide career development and growth opportunity in an outstanding team environment for a noble cause. Opportunity#1: Join a stellar team to create a benchmark facility for Monoclonal antibodies, Gene and Cell Therapies, Cell Culture Medium, Fill Finish and others. Opportunity #2: If you are an experienced professional, you’ll have the opportunity to advance your career and take on increasing responsibilities to grow and lead the Innoforce development and manufacturing teams from Design to Commercialization. Opportunity #3: If you are a fresh/recent grad, we warmly welcome you as well, as we’ll provide you outstanding learning opportunity while you work with world class expertise and leaders as we build the company from ground up. When the company is in full swing GMP operations in a couple years, you will become supervisors and future leaders.
...
查看全部 收起
融資情況
072023
股權投資 未披露
投資機構: 杭州金投
122021
A+輪 3.75億人民幣
投資機構: 勤智資本 / 泉創(chuàng)資本
032021
A輪 6.25億人民幣
投資機構: 中南弘遠 / 勤智資本 / 泉創(chuàng)資本 / 燕園首科資本
052020
Pre-A輪 1.70億人民幣
投資機構: 泉創(chuàng)資本 / 蘋果天使基金 / 薄荷天使基金